MK615, a Prunus mume Steb. Et Zucc (‘Ume’) Extract, Attenuates the Growth of A375 Melanoma Cells by Inhibiting the ERK1/2-Id-1 Pathway

Authors

  • Ko-ichi Tada,

    1. Department of Dermatology, Cardiovascular and Respiratory Disorders Advanced Therapeutics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima,, Japan
    Search for more papers by this author
    • These authors contributed equally to this work.

  • Ko-ichi Kawahara,

    1. Department of Laboratory and Vascular Medicine, Cardiovascular and Respiratory Disorders Advanced Therapeutics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima,, Japan
    2. Laboratory of Functional Foods, Department of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan
    Search for more papers by this author
    • These authors contributed equally to this work.

  • Shigeto Matsushita,

    1. Department of Dermatology, Cardiovascular and Respiratory Disorders Advanced Therapeutics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima,, Japan
    Search for more papers by this author
  • Teruto Hashiguchi,

    1. Department of Laboratory and Vascular Medicine, Cardiovascular and Respiratory Disorders Advanced Therapeutics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima,, Japan
    Search for more papers by this author
  • Ikuro Maruyama,

    1. Department of Laboratory and Vascular Medicine, Cardiovascular and Respiratory Disorders Advanced Therapeutics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima,, Japan
    Search for more papers by this author
  • Takuro Kanekura

    Corresponding author
    • Department of Dermatology, Cardiovascular and Respiratory Disorders Advanced Therapeutics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima,, Japan
    Search for more papers by this author

Takuro Kanekura, Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890–8520, Japan.

E-mail: takurok@m2.kufm.kagoshima-u.ac.jp

Abstract

The Japanese apricot, a commonly consumed food called ‘Ume’ in Japan, has been used for a traditional Japanese medicine for centuries. MK615, an extract of compounds from ‘Ume’, has strong antitumorigenic and antiinflammatory effects including the induction of apoptosis and autophagy, and inhibition of cytokine production mediated via the inhibition of MAPKs signaling including ERK-1/2, JNK and p38MAPK. The inhibitor of DNA binding 1 (Id-1), a basic helix-loop-helix (bHLH) transcription factor family, is essential for DNA binding and the transcriptional regulation of various proteins that play important roles in the development, progression and invasion of tumors. In melanoma, Id-1 is constitutively expressed in the late and early stages, suggesting it as a therapeutic target in patients with melanoma. This study reports that MK615 profoundly reduced both the mRNA- and protein expression levels of Id-1 and inhibited cell growth in A375 melanoma cells. MK615 markedly inhibited the phosphorylation of ERK1/2, which is associated with Id-1 protein expression in A375 cells. Id-1-specific RNAi induced the death of A375 cells. Moreover, the expression of Bcl-2 was decreased by both MK615 and Id-1-specific RNAi in A375 cells. The results suggest that MK615 is a potential therapeutic agent for treating malignant melanoma. Copyright © 2011 John Wiley & Sons, Ltd.

Ancillary